EXCiPACT excipient certification

EXCiPACT Certification Guide for Pharmaceutical Excipient Suppliers

QTC Global Compliance TeamRegulatory reference content

Understand EXCiPACT certification for pharmaceutical excipient suppliers, including GMP, GDP, GWP scope, the 2025 standard update, audit process, certificate verification, and readiness support.

Key answer

EXCiPACT is an international certification scheme for the pharmaceutical excipient supply chain, used to demonstrate appropriate GMP, GDP, or GWP controls for excipient manufacturing, distribution, or warehousing activities. It is not dietary supplement GMP or a standard buyer second-party audit; companies should first confirm whether the material is a pharmaceutical excipient, then confirm the site, activity scope, and customer requirement.

Who usually needs EXCiPACT

EXCiPACT often becomes relevant when a pharmaceutical customer, overseas buyer, or quality agreement asks an excipient supplier to demonstrate GMP/GDP/GWP controls. Buyers need to verify whether the certificate holder, site, scope, and purchased excipient match; suppliers need to prepare system gaps, document evidence, and CAPA before a formal audit.

  • Overseas buyers verifying a Chinese excipient supplier certificate and scope
  • Excipient manufacturers, distributors, or warehouses preparing for third-party certification
  • Suppliers closing gaps, CAPA, or evidence after a customer audit

GMP vs GDP vs GWP: what each scope means

A simple way to understand the EXCiPACT scope is: GMP focuses on how the excipient is made, GDP focuses on how it moves through distribution, and GWP focuses on how it is warehoused. A company may need one scope or a combination depending on its activities.

  • GMP: production process, equipment, personnel, cleaning, contamination control, batch records, quality control, deviations, and CAPA.
  • GDP: customer and supplier controls, traceability, storage and transport conditions, returns, recalls, and prevention of mix-ups.
  • GWP: warehouse conditions, stock status, identification, segregation, contamination prevention, damage prevention, stock rotation, and record integrity.

Certification is handled through registered bodies

The official EXCiPACT certification process typically includes selecting a registered certification body, defining site and standard scope, Stage 1 document review, Stage 2 on-site audit, independent certification decision, a 3-year certificate cycle, at least annual surveillance audits, and recertification before expiry. The 2025 standard has been released, and the official announcement expects audits after September 1, 2026 to use the new edition.

  • The certificate is generally tied to a specific site, standard scope, and activity scope.
  • When verifying a certificate, buyers should check whether the purchased excipient and supplier activity are covered.
  • Readiness support includes gap analysis and remediation coaching. Certification decisions and certificates are independently issued by registered certification bodies.

Evidence to prepare before an audit

EXCiPACT readiness is not only document collection. The quality system, site practice, records, and customer requirement need to align. The exact list depends on site activity and applicable scope, but preparation usually starts with the quality system, supplier controls, change control, deviations and complaints, traceability, storage and transport, internal audits, and CAPA.

  • Quality manual, SOP list, responsibility matrix, training records, and management review.
  • Supplier qualification, incoming controls, batch records, release, traceability, and storage/transport records.
  • Change control, deviations, complaints, recalls, CAPA, and previous customer audit findings.

Common confusion: EXCiPACT, second-party audit, and supplement GMP

EXCiPACT should be understood in the pharmaceutical excipient context. A second-party audit supports a buyer’s supplier management decision and can be tailored to the quality agreement; EXCiPACT is a third-party certification scheme performed by registered certification bodies and auditors. 21 CFR Part 111 belongs to the U.S. dietary supplement GMP context and should not be the main target of this page.

  • Do not automatically apply EXCiPACT to all food ingredients, additives, or supplement ingredients.
  • Audit timing and cost usually depend on site scope, activity complexity, certification body scheduling, and CAPA workload.
  • When facing EXCiPACT requirements, start by confirming material use, site activity, target customer requirement, and existing certificate status.

Certification Readiness Support

Certification readiness support covers three areas: gap assessment to understand the gap between current systems and EXCiPACT requirements; evidence preparation to organize quality systems, production records, supplier files, and CAPA records into an auditable chain; audit preparation to reduce document and site inconsistency risks before the formal audit. For buyers, certificate scope and supplier risk verification support is also available.

  • For buyers: verify certificate holder, site, scope, purchased excipient, and supplier activity match.
  • For suppliers: pre-audit gap assessment, document and site evidence preparation, and CAPA closure.
  • Project level: translate customer requirements into a practical evidence list, timeline, and responsibility plan.

FAQ

Is EXCiPACT a pharmaceutical excipient GMP certification?+

Broadly yes, but more precisely, EXCiPACT is a pharmaceutical excipient supply chain certification scheme. The applicable scope may be GMP, GDP, GWP, or a combination depending on whether the organization manufactures, distributes, warehouses, or combines these activities.

Where can buyers check EXCiPACT certificate holders?+

EXCiPACT provides an official certificate holders page. Buyers should check the certificate holder, site address, certification scope, GMP/GDP/GWP activity scope, validity period, and whether the purchased excipient is covered: https://www.excipact.org/certificate-holders.html

How should a buyer verify a Chinese supplier’s EXCiPACT certificate?+

Check the certificate holder, site address, certification scope, GMP/GDP/GWP activity scope, validity period, and whether the purchased excipient is covered. Where needed, combine this with the quality agreement, recent audit findings, and CAPA status to assess supplier risk.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.